Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience
References (41)
- et al.
[111In-DTPA-D-Phe1]-Octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: Synthesis, radiolabeling and in vitro validation
Life Sci
(1991) - et al.
Tolerance of normal tissue to therapeutic irradiation
Int J Radiat Oncol Biol Phys
(1991) - et al.
Yttrium-90-labelled somatostatin-analogue for cancer treatment
Lancet
(1998) - et al.
The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study
Ann Oncol
(2001) - et al.
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients
Eur J Nucl Med
(1993) - et al.
Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history
Ann N Y Acad Sci
(1994) - et al.
Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors
J Nucl Med
(2000) - et al.
Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: Peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy
Nucl Med Commun
(1998) - et al.
The radiation dose to cells in vitro from intracellular indium-111
Biochem Cell Biol
(1989) - et al.
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: Metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide
J Nucl Med
(1992)
Imaging with octreoscan: Haste makes waste
Eur J Nucl Med
(1999)
Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: Development of a specific radioimmunoassay for chromogranin A and its fragments
J Endocrinol
(1993)
Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma
Br J Cancer
(2001)
Reporting results of cancer treatment
Cancer
(1981)
Natural history of neuroendocrine enteropancreatic tumors
Digestion
(2000)
Health-related quality of life in patients with endocrine tumours of the gastrointestinal tract
Acta Oncol
(1999)
Quality of life in patients with gastrointestinal tumours
In situ radiotherapy with 111In-pentetreotide: Initial observations and future directions
Cancer J Sci Am
(1998)
Treatment of neuroendocrine GEP tumours with somatostatin analogues: A review
Digestion
(2000)
In-111-octreotide therapy: Phase I–II trial
J Nucl Med
(1999)
Cited by (369)
Radioactivity of biological samples of patients treated with <sup>90</sup>Y-DOTATOC
2023, Nuclear Engineering and TechnologySystemic Therapy for Pancreatic Neuroendocrine Tumors
2023, Clinical Colorectal CancerTherapy of NET with radiolabeled SST analogs
2022, Nuclear Medicine and Molecular Imaging: Volume 1-4Sequencing of Somatostatin-Receptor–Based Therapies in Neuroendocrine Tumor Patients
2024, Journal of Nuclear Medicine
Copyright © 2002 Published by Elsevier Inc.